CN1434058A - Radix cyathulae fructosan, preparation process and use thereof - Google Patents
Radix cyathulae fructosan, preparation process and use thereof Download PDFInfo
- Publication number
- CN1434058A CN1434058A CN 03115429 CN03115429A CN1434058A CN 1434058 A CN1434058 A CN 1434058A CN 03115429 CN03115429 CN 03115429 CN 03115429 A CN03115429 A CN 03115429A CN 1434058 A CN1434058 A CN 1434058A
- Authority
- CN
- China
- Prior art keywords
- root
- polylevulosan
- medicinal cyathula
- cyathula
- medicinal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention relates to a production method for extracting fructosan from Chinese medicinal material radix cyathula and its application. Said method includes the following steps: soaking cyathula root in water to obtain aqueous extract of radix cyathula, using organic solvent to make preciptiation, dissolving the precipitate with water, making supernatnat fluid undergo the processes of dialysis or membrane separation, concentration and drying to obtain total polysaccharide, and making the obtained cyathula total polysaccharide undergo the process of column chromatography to make purification so as to obtain the cyathula fructosan CoPS. Said invention provides its chemical structure formula. It can be used for preparing medicine and health-care product with the actions of resisting tumor and raising immunological function.
Description
Technical field
The present invention relates to from the Chinese medicine Root of Medicinal Cyathula, extract Root of Medicinal Cyathula Polylevulosan and total polysaccharides thereof, Preparation method and use.
Background technology
Root of Medicinal Cyathula (Cyathula Officinals Kuan) is a kind of traditional Chinese medicine material, have by the stasis of blood stimulate the menstrual flow, the effect of easing joint movement, inducing diuresis for treating stranguria syndrome.Bibliographical information, [Ma Ying etc., herbal medicine, 31 (6), 427 (2000)], its chemical ingredients is mainly alkaloid and ketosteroid, as: cyasterone, capitasterone etc.And the research of relevant Root of Medicinal Cyathula saccharide compound does not appear in the newspapers as yet.
Summary of the invention
The problem to be solved in the present invention provides Root of Medicinal Cyathula Polylevulosan CoPS and total polysaccharides, its production method and purposes.
The invention provides and extract the Polylevulosan that obtains from the Chinese medicinal materials Root of Medicinal Cyathula, its chemical structure is as follows:
The present invention also provides the total polysaccharides of described Root of Medicinal Cyathula Polylevulosan, it is by the preparation of following method: dried Chinese medicinal materials Root of Medicinal Cyathula is soaked in water, with or without organic solvent deposit, the precipitation water dissolution, supernatant liquor is behind dialysis or membrane sepn, and concentrate drying obtains total polysaccharides.Contain 60～99% Root of Medicinal Cyathula Polylevulosan CoPS in the total polysaccharides of the Root of Medicinal Cyathula Polylevulosan of recommending, especially contain 95% Root of Medicinal Cyathula Polylevulosan CoPS in the total polysaccharides of the Root of Medicinal Cyathula Polylevulosan of Tui Jianing.
Preparation method of the present invention boils the Root of Medicinal Cyathula section with cold water soak or hot water, adopt organic solvent deposit, dialysis or membrane sepn, and concentrate drying obtains total polysaccharides.Total polysaccharides obtains the pure product CoPS of Root of Medicinal Cyathula Polylevulosan through ion exchange column and gel filtration chromatography.
This Polylevulosan is through acid hydrolysis fully, and the HPLC analysis is learnt by fructose and glucose and formed.Recording its molecular weight distribution by ESI-MS and HPLC is 1000～10000Da.The data of its infared spectrum are as follows: 3700～3000cm
-1Strong broad peak be intermolecular and the intramolecularly hydroxyl absorbs, 2950～2870cm
-1Be c h bond stretching vibration, 1400～1200cm
-1Be the angle vibration of C-H, 1000～1200cm
-1Be C-O-C ehter bond asymmetrical stretching vibration on the sugar ring, 929cm
-1Be the symmetrical stretching vibration of furan nucleus, 815cm
-1C-H angle vibration for furan nucleus.
Its nuclear magnetic resonance spectrum diagram data is as follows: δ (ppm):
1H-NMR:5.307 be α-Glc (1 →.
13C-NMR: chemical shift data δ 62.6～63.9,105.8～106.8,78.9～79.8,76.8～77.9 or 82.9～83.7,64.9～66.0ppm on the fructose furan nucleus, chemical shift data δ 95.1,73.8,75.0,71.8,73.7, the 62.6ppm of the carbon on the glucose pyranoid ring.(its error is ± 0.5ppm)
Preparation method of the present invention comprises the Root of Medicinal Cyathula medicinal material is soaked in water, and adopts organic solvent deposit, dialysis or membrane sepn, and concentrate drying obtains the Root of Medicinal Cyathula total polysaccharides.The Root of Medicinal Cyathula total polysaccharides can get the pure product CoPS of Root of Medicinal Cyathula Polylevulosan through ion exchange column and gel filtration chromatography purifying.
Specifically, with dried Root of Medicinal Cyathula pulverizing medicinal materials or section, be soaked in water, wherein the weight ratio recommendation of Root of Medicinal Cyathula medicinal material and water logging bubble is a Root of Medicinal Cyathula: water=1: 8～15, especially recommend to soak 36～48 hours with 10～12 times of weight or more water.Described water is recommended as deionized water.The pH value of soak solution recommends to remain on 6.0～8.0.
Filter, filtrate through or without concentrating, with centrifugal behind the organic solvent deposit.Centrifugal gained precipitation water dissolution is recommended the water dissolution with 1-5 times of weight.
Centrifugal, supernatant liquor dialysis or membrane sepn, dialysis time is recommended as 24-72 hour, and dialysis recommends molecular weight cut-off below 1000 with dialysis membrane, dialysis tubing, its aperture, and especially recommending molecular weight cut-off is 500～1000.
Concentrate drying obtains total polysaccharides, and wherein drying or concentrating under reduced pressure temperature are recommended to be lower than 60 ℃ and carried out, and preferably adopt cryogenic vacuum to concentrate or lyophilize, and for example 30～60 ℃ of dryings or concentrate, pressure recommends to be controlled at 0.08～0.10MPa.
Described Root of Medicinal Cyathula total polysaccharides is dissolved in water, and wherein recommends the water dissolution of 1～5 times of weight.Through CM-Sephadex C-50 column chromatography, purity can reach 95%.Be further purified through gel filtration chromatography, water or rare salts solution wash-out are collected sugared peak again, and lyophilize obtains the pure product CoPS of Root of Medicinal Cyathula Polylevulosan, and purity can reach 99%.The gel that gel filtration chromatography adopted is Sephadex G type, Sephacryl S type, Superose type, Bio-Gel P type or Superdex, and the separating ranges of selecting for use is 1 * 10
2-5.0 * 10
4Dalton.Recommend gel Sephadex G-50, with 0.1mol/L NaCl wash-out.
The aforesaid organic solvent deposit of using, the organic solvent that described organic solvent is recommended and water dissolves each other can be the alcohol or the ketone of low carbon chain, for example C
1～C
6Alcohol or ketone etc., especially recommend acetone, for example use 75%～95% acetone of 2～6 times of volumes; Sedimentation time is recommended as 12～36 hours.
The present invention extracts Root of Medicinal Cyathula Polylevulosan CoPS first from Root of Medicinal Cyathula.Extraction and separation method of the present invention is easy, and the productive rate height is suitable for suitability for industrialized production.Through biological activity test, result of study shows that Root of Medicinal Cyathula Polylevulosan CoPS has the effect that suppresses Lewis lung cancer preferably, and has the active effect of enhancing immunity.
Description of drawings
Fig. 1 is the HPLC figure of Root of Medicinal Cyathula Polylevulosan CoPS.Analytical column is TSK, elutriant: water, and flow velocity: 1mL/min, detector: RI analyzes and obtains single symmetrical peak, shows that it has homogeneity.
Fig. 2 is the CE figure of Root of Medicinal Cyathula Polylevulosan CoPS.Elutriant: 100mmol/LH
3BO
3-KOH (pH=10), voltage: 12KV detects wavelength: 254nm, analyzes and also obtains single symmetrical peak, shows that it has homogeneity.
Fig. 3 is the IR figure of Root of Medicinal Cyathula Polylevulosan CoPS.Instrument is the FTS185 type infrared spectrometer of Bio-Rad company.
Fig. 4 is Root of Medicinal Cyathula Polylevulosan CoPS
1H-nucleus magnetic resonance (NMR) collection of illustrative plates.Instrument is the Bruker-MX-400 nuclear magnetic resonance analyser.Solvent is a heavy water.
Fig. 5 is Root of Medicinal Cyathula Polylevulosan CoPS
13C-nucleus magnetic resonance (NMR) collection of illustrative plates.Instrument is the Bruker-MX-400 nuclear magnetic resonance analyser.Solvent is a heavy water.
Fig. 6 is the HPLC figure of Root of Medicinal Cyathula Polylevulosan CoPS monose compositional analysis.Analytical column is Carbohydrate Analysis, elutriant: acetonitrile: water (82: 18), detector: RI.
Fig. 7 is gas phase (GC) collection of illustrative plates of Root of Medicinal Cyathula Polylevulosan CoPS methylate.Instrument is a Shimadzu QP5000 chromatograph mass spectrometer.
Fig. 8,9,10,11,12,13,14, the 15th, mass spectrum (MS) figure of Root of Medicinal Cyathula Polylevulosan CoPS methylate.Wherein Fig. 8 is corresponding to the peak of 3.22min among Fig. 7, and showing has terminal glucose; Fig. 9,10 corresponds respectively to the peak of 3.27min and 3.40min among Fig. 7, and showing has terminal fructose; Figure 11,13 corresponds respectively to the peak of 5.41min and 5.74min among Fig. 7, and showing has 1,2 fructose that connects; Figure 12 is corresponding to the peak of 5.63min among Fig. 7, and showing has 2,6 fructose that connect; Figure 14,15 corresponds respectively to the peak of 8.13min and 8.58min among Fig. 7, shows the fructose that side chain is arranged.
Embodiment
With Root of Medicinal Cyathula medicinal material 100g clean dry, section, with 1 liter of deionized water soaking at room temperature 48 hours, filtration.Residue continues to soak 12 hours with 1 liter of deionized water, filters, and merging filtrate, 60 ℃ of concentrating under reduced pressure are used the ethanol sedimentation of 5 times of volumes 95% then, and precipitation left standstill 24 hours.Centrifugal, precipitation is dissolved with 100 ml waters, and is centrifugal, is that lyophilize promptly obtains Root of Medicinal Cyathula total polysaccharides 15～17g behind 1000 the membrane sepn with molecular weight cut-off.
Embodiment 2
With Root of Medicinal Cyathula medicinal material 100g clean dry, section, with 1.2 liters of deionized water soaking at room temperature 48 hours, filtration.Residue continues to soak 12 hours with 1 liter of deionized water, filters, and merging filtrate, 50 ℃ of concentrating under reduced pressure are used the acetone precipitation of 3 times of volumes 95% then, and precipitation left standstill 24 hours.Centrifugal, precipitation is with the dissolving of 100 ml waters, and is centrifugal, deionized water dialysis 72 hours.50 ℃ of concentrating under reduced pressure postlyophilizations promptly obtain Root of Medicinal Cyathula total polysaccharides 13～15g.
Embodiment 3
With Root of Medicinal Cyathula medicinal material 100g clean dry, section, with 0.8 liter of deionized water soaking at room temperature 48 hours, filtration.Residue continues to soak 12 hours with 0.5 liter of deionized water, filters, and merging filtrate, 50 ℃ of concentrating under reduced pressure, deionized water dialysis 72 hours, centrifugal.50 ℃ of concentrating under reduced pressure postlyophilizations promptly obtain Root of Medicinal Cyathula total polysaccharides 15～17g.
Embodiment 4
With Root of Medicinal Cyathula medicinal material 100g clean dry, pulverize, boiled 6 hours with 1.5 liters of deionized water boiling water, filter.Residue continued to boil 6 hours with 1 liter of deionized water, filters, and merging filtrate, 50 ℃ of concentrating under reduced pressure are used the acetone precipitation of 2 times of volumes 95% then, and precipitation left standstill 24 hours.Centrifugal, precipitation is with the dissolving of 100 ml waters, and is centrifugal, deionized water dialysis 72 hours.50 ℃ of concentrating under reduced pressure postlyophilizations promptly obtain Root of Medicinal Cyathula total polysaccharides 13～15g.
Embodiment 5
The Root of Medicinal Cyathula total polysaccharides is refining through CM-Sephadex C-50 column chromatography, and purity is 95%, again through Sephadex G-50 column chromatography, promptly obtains purity and be 99% Root of Medicinal Cyathula Polylevulosan CoPS.Concrete separation method: take by weighing Root of Medicinal Cyathula total polysaccharides 100mg, be dissolved in 2～3mL distilled water, centrifugal (4500r/min, 10min).(1.5cm * 120cm), with 0.1M NaCl wash-out, flow velocity is 0.5mL/min, and every pipe is collected 3～5mL and detected sugared peak to get supernatant liquor upper glass post.Collect the back desalination, lyophilize promptly obtains pure Polylevulosan CoPS 80～90mg.
The ultimate analysis of embodiment 6 Root of Medicinal Cyathula Polylevulosan CoPS
Root of Medicinal Cyathula Polylevulosan CoPS after 5 hours, is carried out carbon, hydrogen, nitrogen ultimate analysis 110 ℃ of dryings.Elemental analyser is a CARIO-ERBA element automatic analyser.The result is as follows:
Carbon percentage composition: 41.36% (± 0.8%)
Hydrogen percentage composition: 6.63% (± 0.3%)
Nonnitrogenous element.
The bioactivity research of embodiment 7 Root of Medicinal Cyathula Polylevulosan CoPS
We are to the Root of Medicinal Cyathula Polylevulosan CoPS of various dose censorship biological activity determination, and its result is as follows: 1. Root of Medicinal Cyathula Polylevulosan CoPS is to one of the clinical trial of the Mice Bearing Lewis Lung Cancer toes inoculation heavy inhibiting rate of sample dose administration number of animals the weight of animals knurl
Mg/kg scheme beginning/whole X at beginning/end ± SD %CoPS 200 ip * 10qd 8/8 20.4/24.1 0.488 ± 0.04 49.17
*Control group NS ip * 10qd 16/16 20.4/24.3 0.960 ± 0.15/
* represents that test group compares p＜0.012. Root of Medicinal Cyathula Polylevulosan CoPS to the heavy inhibiting rate of two sample dose administration number of animals the weight of animals knurls of the clinical trial of Mice Bearing Lewis Lung Cancer toes inoculations with negative control group
Mg/kg scheme beginning/whole X at beginning/end ± SD %CoPS 100 ip * 10qd 8/8 20.9/25.1 0.620 ± 0.04 40.95
*Control group NS ip * 10qd 16/16 21.0/25.5 1.05 ± 0.16/
* represents that test group compares p＜0.01 with negative control group
Claims (10)
1, a kind of Root of Medicinal Cyathula Polylevulosan CoPS, its feature structure is as follows:
2, Root of Medicinal Cyathula Polylevulosan as claimed in claim 1 is characterized in that molecular weight ranges is 1000～10000.
3, the total polysaccharides of Root of Medicinal Cyathula Polylevulosan as claimed in claim 1, it is characterized in that by the preparation of following method: dried Chinese medicinal materials Root of Medicinal Cyathula is soaked in water, with or without organic solvent deposit, the precipitation water dissolution, supernatant liquor is behind dialysis or membrane sepn, and concentrate drying obtains total polysaccharides.
4, the total polysaccharides of Root of Medicinal Cyathula Polylevulosan as claimed in claim 3 is characterized in that containing 60～99% Root of Medicinal Cyathula Polylevulosan CoPS.
5, as the production method of claim 1 or 3 described Root of Medicinal Cyathula Polylevulosan and total polysaccharides thereof, it is characterized in that comprising dried Chinese medicinal materials Root of Medicinal Cyathula is soaked in water, with or without organic solvent deposit, precipitation is used water dissolution, supernatant liquor is behind dialysis or membrane sepn, and concentrate drying obtains total polysaccharides.
6, want the production method of 5 described Root of Medicinal Cyathula Polylevulosan as right, it is characterized in that the Root of Medicinal Cyathula total polysaccharides is dissolved in water after, column chromatography purification can get the pure product CoPS of Root of Medicinal Cyathula Polylevulosan.
7, the production method of Root of Medicinal Cyathula Polylevulosan as claimed in claim 5 is characterized in that the weight ratio Root of Medicinal Cyathula that medicinal material Root of Medicinal Cyathula and water logging are steeped: water=1: 5～15, water-soaking time 24～48 hours, the pH=6 of soak solution～8.
8, the production method of Root of Medicinal Cyathula Polylevulosan as claimed in claim 5 is characterized in that described organic solvent is the organic solvent that dissolves each other with water.
9, the production method of Root of Medicinal Cyathula Polylevulosan as claimed in claim 5, it is characterized in that the gel that described gel filtration chromatography adopts is Sephadex G type, Sephacryl S type, Superose type, Bio-Gel P type or Superdex, the separating ranges of selecting for use is 1 * 10
2-5.0 * 10
4Dalton.
10,, it is characterized in that described Root of Medicinal Cyathula Polylevulosan is used to prepare and has antitumor and medicine or healthcare products raise immunity as the purposes of claim 1 or 3 described Root of Medicinal Cyathula Polylevulosan and total polysaccharides thereof.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 03115429 CN1208349C (en) | 2003-02-14 | 2003-02-14 | Radix cyathulae fructosan, preparation process and use thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 03115429 CN1208349C (en) | 2003-02-14 | 2003-02-14 | Radix cyathulae fructosan, preparation process and use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1434058A true CN1434058A (en) | 2003-08-06 |
| CN1208349C CN1208349C (en) | 2005-06-29 |
Family
ID=27634251
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 03115429 Expired - Fee Related CN1208349C (en) | 2003-02-14 | 2003-02-14 | Radix cyathulae fructosan, preparation process and use thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1208349C (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102558380A (en) * | 2012-01-19 | 2012-07-11 | 陈清华 | Achyranthes bidentata polysaccharides extraction and purification method |
| CN102617749A (en) * | 2012-04-11 | 2012-08-01 | 山东大学 | Method for preparing ABPS |
| CN105859904A (en) * | 2016-04-29 | 2016-08-17 | 南京安吉生物科技有限公司 | Achyranthes aspera stem and/or leaf and/or root extract and extraction method and application thereof |
| CN107098984A (en) * | 2016-02-23 | 2017-08-29 | 中国人民解放军军事医学科学院毒物药物研究所 | Root of bidentate achyranthes Thick many candies, polysaccharide component and homogeneous polysaccharide, Its Preparation Method And Use |
| CN107383225A (en) * | 2017-06-29 | 2017-11-24 | 华东师范大学 | A kind of anti-tumor drug levulan carboxylate and its synthetic method |
-
2003
- 2003-02-14 CN CN 03115429 patent/CN1208349C/en not_active Expired - Fee Related
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102558380A (en) * | 2012-01-19 | 2012-07-11 | 陈清华 | Achyranthes bidentata polysaccharides extraction and purification method |
| CN102617749A (en) * | 2012-04-11 | 2012-08-01 | 山东大学 | Method for preparing ABPS |
| CN107098984A (en) * | 2016-02-23 | 2017-08-29 | 中国人民解放军军事医学科学院毒物药物研究所 | Root of bidentate achyranthes Thick many candies, polysaccharide component and homogeneous polysaccharide, Its Preparation Method And Use |
| CN105859904A (en) * | 2016-04-29 | 2016-08-17 | 南京安吉生物科技有限公司 | Achyranthes aspera stem and/or leaf and/or root extract and extraction method and application thereof |
| CN107383225A (en) * | 2017-06-29 | 2017-11-24 | 华东师范大学 | A kind of anti-tumor drug levulan carboxylate and its synthetic method |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1208349C (en) | 2005-06-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kuang et al. | Screening and comparison of the immunosuppressive activities of polysaccharides from the stems of Ephedra sinica Stapf | |
| US20180193373A1 (en) | Method for Preparing Linseed Polysaccharide Having Antiviral Activity and Immunological Activity, and Use of the Linseed Polysaccharide | |
| CN116217745B (en) | Vine tea polysaccharide, preparation method and application | |
| CN1648136A (en) | Companumoea root polyose, derivative and its preparing method and use | |
| CN111410698A (en) | Camel thorn sugar polymer and preparation method and application thereof | |
| CN1208349C (en) | Radix cyathulae fructosan, preparation process and use thereof | |
| CN1965894B (en) | Prunella vulgaris polysaccharide having immune activity, preparation method and application thereof | |
| CN1173996C (en) | Atractylodes polyose with antineoplastic and immunoregualting functions and its preparing process and application | |
| CN115894731B (en) | Anoectochilus formosanus uniform polysaccharide and preparation method and application thereof | |
| CN100438878C (en) | Active largehead atractylodes saccharide complex for reducing blood sugar and its prepn and use | |
| CN113717296B (en) | Eucommia acidic polysaccharide, extraction method and application of eucommia acidic polysaccharide in preparation of anti-colon cancer drugs | |
| CN1266164C (en) | Lucid ganoderma spore powder polysaccharide, production method and use | |
| CN1264529C (en) | Freeze-dried 'Shenqifuzheng' powder for injection and its preparing process | |
| CN1179968C (en) | Scrophularia oligose, production method and use thereof | |
| CN1286853C (en) | Figwort polysaccharide and its production process and use | |
| CN109234335B (en) | Preparation method of polysaccharide rich in galactofuranose in tabasheer | |
| CN114409818A (en) | Preparation method and application of physalis pubescens polysaccharide selenide | |
| CN108948223B (en) | Myrtle polysaccharide P1, its separation method and application in preparing hypolipidemic medicine | |
| CN108997509B (en) | Diaphragma juglandis polysaccharide, preparation method and application thereof | |
| CN112279841A (en) | Antiviral andrographolide derivative and preparation method thereof | |
| CN1730027A (en) | Method for preparing anti-hepatitis active part from swertia main pharmaceutical plant | |
| CN112480282A (en) | Cyclocarya paliurus polysaccharide component and preparation method thereof | |
| CN1398901A (en) | Prepn and use of curcuma oligosaccharide sulfate derivative | |
| CN1327811A (en) | Active component of fleabane flower and its preparing process and preparation | |
| CN115141288B (en) | Rhizoma anemarrhenae active polysaccharide, rhizoma anemarrhenae crude polysaccharide, and preparation method and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |